Sign in
Taking people in United StatesPhase 4

Two ways to control pain after total shoulder surgery for shoulder osteoarthritis

Compares a nerve catheter with a single Exparel injection for pain after shoulder replacement.

Key facts

Who runs it
Melinda Seering
Where
Iowa City, United StatesSee the site
Trial code
Registry title
Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
Status
Recruiting
Phase
Phase 4
People taking part
56 people, planned
Started
19 Aug 2024
Expected to end
Jan 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Interscalene Catheter
  • Exparel Single Shot Interscalene Block
Record updated
10 November 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults having planned reverse shoulder replacement surgery. It compares two ways of numbing the nerves of the shoulder to control pain after surgery.

Age
18 Years to 90 Years (at least 18 and less than 90 years old).
Sex
All sexes can join.
Disease stage
Planned, non-emergency reverse shoulder replacement surgery with the orthopedics service. ASA class I, II, or III (a score of general health before anesthesia).
Earlier treatment
People who regularly took opioid pain medicine before surgery (greater than 20 MME) cannot join. People having a repeat (revision) shoulder surgery cannot join.

Main reasons for not taking part

  • Taking blood thinners or other reasons a nerve block cannot be done
  • Serious lung disease, or allergy to Exparel, Bupivacaine or Ropivacaine
  • Nerve damage (neuropathy) in the arm to be numbed
  • Documented kidney failure or liver failure
  • Pregnancy, a shoulder fracture, or being unable to communicate in English

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Patients who have or are:
  • Orthopedics service patients having reverse shoulder replacement surgery
  • ASA class I, II, or III
  • Patients at least 18 years old but less than 90 years old
  • Patients giving informed consent
  • Non-Emergency Surgery

Who cannot take part

  • Revision surgery
  • Significant pulmonary disease or allergy to medications used for peripheral nerve blocks (Exparel, Bupivacaine and Ropivacaine)
  • Documented Kidney Failure
  • Documented Liver Failure
  • Patients who have or are:
  • An inability to cooperate during the block placement
  • Patients who do not meet criteria for a regional block: such as those on anti-coagulation,
  • Neuropathy of the planned extremity to block
  • A lack of or inability to give informed consent
  • Currently incarcerated
  • Pregnant
  • Unable to communicate in English
  • Chronic pre-operative opioid use (greater than 20 MME opioid used)
  • Fracture

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

Where in United States

  • University of Iowa Hospital and ClinicsIowa City, United StatesContact: Melinda Seering, M.D.Taking people

About the trial

What the trial wants to find out

Comparison of post-operative pain after total shoulder surgery. The Principle Investigator will be comparing Exparel single shot block to Interscalene catheter

The 2 groups in the trial

  • Interscalene CatheterExisting treatment, for comparison

    One of the current standard of care for shoulder replacement surgery at our institution is to receive an interscalene catheter for pre-operatively

  • Exparel Single Shot Interscalene BlockExisting treatment, for comparison

    One of the current standard of care for shoulder replacement surgery at our institution is to receive a pre-operative single shot interscalene block with Exparel

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Feasibility Randomized Control Comparison of Peripheral Interscalene Catheter to Liposomal Bupivacaine Single Injection for Interscalene Blocks Used in Pain Control for Total Shoulder Arthroplasties
Plain-language title
Two ways to control pain after total shoulder surgery for shoulder osteoarthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05868330, who can take part
Record updated
10 November 2025